State regulation of the pharmaceutical and medical industry

This article presents an analysis and identification of the main areas of the pharmaceutical and medical industry, as well as an assessment of the effectiveness of state regulation of the pharmaceutical and medical industry of the Russian Federation using the results of the implementation of the state program "Development of the medical and pharmaceutical industry of the Russian Federation" for 2013-2020. and the draft Strategy for the development of the medical industry of the Russian Federation for the period up to 2030”. The aim of the work is to study the basics of state regulation of the pharmaceutical and medical industries and consider the prospects for the development of the domestic pharmaceutical industry and the mechanisms of state regulation of the production of medical preparations. The scientific novelty of the study lies in the synthesis of existing strategies and methods of state regulation of the medical and pharmaceutical industry of the Russian Federation and the formation of proposals for a specific way of regulating the industry. The authors came to the conclusion that the main strategic guideline for the domestic pharmaceutical industry in 2030 should be import substitution based on the accelerated introduction of promising domestic drug developments.